Page last updated: 2024-10-27

foscarnet and Arterial Occlusive Diseases

foscarnet has been researched along with Arterial Occlusive Diseases in 1 studies

Foscarnet: An antiviral agent used in the treatment of cytomegalovirus retinitis. Foscarnet also shows activity against human herpesviruses and HIV.
phosphonoformic acid : Phosphoric acid in which one of the hydroxy groups is replaced by a carboxylic acid group. It is used as the trisodium salt as an antiviral agent in the treatment of cytomegalovirus retinitis (CMV retinitis, an inflamation of the retina that can lead to blindness) and as an alternative to ganciclovir for AIDS patients who require concurrent antiretroviral therapy but are unable to tolerate ganciclovir due to haematological toxicity.

Arterial Occlusive Diseases: Pathological processes which result in the partial or complete obstruction of ARTERIES. They are characterized by greatly reduced or absence of blood flow through these vessels. They are also known as arterial insufficiency.

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's1 (100.00)18.2507
2000's0 (0.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Calligaro, KD1
Stern, J1
DeLaurentis, DA1

Other Studies

1 other study available for foscarnet and Arterial Occlusive Diseases

ArticleYear
Foscarnet: a possible cause of ulnar artery thrombosis in a patient with AIDS.
    Journal of vascular surgery, 1994, Volume: 20, Issue:6

    Topics: Acquired Immunodeficiency Syndrome; Adult; Arterial Occlusive Diseases; Foscarnet; Humans; Male; Per

1994